US Pharmaciasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-10-09
Share capital
15 489 000,00 PLN
Activity description

US Pharmacia is a Wrocław-based manufacturer of over-the-counter medicines such as Apap, Ibuprom and Gripex, and the leading supplier of medicinal products to the USP Group. It offers contract manufacturing for pharmaceutical and supplement companies, including technology transfer, production and quality control.

Registered address
Ziębicka 40, 50-507 Wrocław, Poland
Website
uspharmacia.plWebsite active
Phone
Social media
Electronic delivery address
AE:PL-39678-89265-AUUEU-25

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 41.27mMedianUSD 782.27kAverageUSD 24.03m
Net profit
This companyUSD 5.96mMedianUSD 7.91kAverageUSD 2.59m
Operating costs
This companyUSD 33.76mMedianUSD 723.93kAverageUSD 19.92m
Assets
This companyUSD 104.78mMedianUSD 800.34kAverageUSD 29.11m

Bank accounts

Registered as a VAT taxpayer on 1996-09-16. Active

  • mBank
    02 1140 2062 0000 4797 6200 1014
  • mBank
    18 1140 2062 0000 4797 6200 1017
  • mBank
    29 1140 2062 0000 4797 6200 1013

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$7.6M
Buildings and premises
$10.7M

Public aid

PurposeGross amount
Aid for research and development projects: experimental development
$2.0M
Aid for research and development projects: industrial research
$129.3K
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$10,165

European Funds

ProjectEU co-financing
Opracowanie innowacyjnych rozwiązań zapewniających wzrost efektywności i wydajności kluczowych procesów wytwarzania leków OTC oraz przyczyniających się do wzrostu ich bezpieczeństwa mikrobiologicznego
$2.1M

Tenders

No recorded participation in tenders.

Trademarks

US Pharmacia currently holds no active trademarks with the Polish Patent Office. 7 marks have expired or were not registered. The first mark was filed in 1999.

MarkProtected until
Dropzol(word)–
Contracold–
Mark without a word element(figurative)–
Duopirine(word)–
Loperamid USP(word)–

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Authorized Representatives

Agnieszka Fabiańczyk – Attorney-in-fact (joint)
Marcin Andrzej Szałapski – President of the Management Board
Małgorzata Brzozowska Bejgier – Attorney-in-fact (joint)
Maria Jedynak Pałac – Attorney-in-fact (joint)
Tomasz Marchewa – Management Board Member

Manner of representation

The President of the Management Board is authorized independently to submit declarations of will and sign contracts in the name of the company. Joint action of two members of the management board or one member of the management board together with a commercial proxy is required for declarations of will in the name of the company to be submitted by the remaining members of the management board.

Supervisory board

Katarzyna Anna Kuśmierz – Supervisory Board Member
Fracis Patrick Ostronic – Supervisory Board Member
Kazimierz Janusz Napiórkowski – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Medvic S.a.r.l
30,978$4,183,954.62100%

Beneficial owners

Person

Change history

DateEvent
2007-05-10Share capital change
2003-05-08Share capital change
2001-10-09Entered in the register

FAQ

Last updated: 2026-10-07